Table 2.
Available meningococcal vaccines.
| Serogroup | Vaccine Formulation | Vaccine Type | Vaccine Name | Manufacturer |
|---|---|---|---|---|
| A | MenA-TT | Conjugate | MenAfri Vac83 | Serum Institute of India |
| B | MenB-FHbp | Recombinant (FHbp subfamily A and B) | Trumenba70 | Pfizer |
| MenB-4C | Recombinant (FHbp subfamily B, NadA, NHBA, OMV) | Bexsero72 | GlaxoSmithKline | |
| C | MCC-TT | Conjugate | NeisVac-C53 | Pfizer |
| MCC-TT | Conjugate | Menitorix120 | GlaxoSmithKline | |
| MCC-CRM | Conjugate | Menjugate52 | GlaxoSmithKline | |
| MCC-CRM | Conjugate | Meningitec51 | Pfizer | |
| C + Y | Hib-MenCY-TT | Conjugate | MenHibrix121 | GlaxoSmithKline |
| ACWY | MenACWY-DT | Conjugate | Menactra122 | Sanofi Pasteur |
| MenACWY-CRM | Conjugate | Menveo63 | GlaxoSmithKline | |
| MenACWY-TT | Conjugate | Nimenrix123 | Pfizer |
CRM = cross-reactive material; DT = diphtheria toxoid; FHbp = factor H binding protein; Hib = Haemophilus influenzae type B; MCC = meningococcal serogroup C conjugate; NadA = neisserial adhesin A; NHBA = neisserial heparin-binding antigen; OMV = outer membrane vesicles; TT = tetanus toxoid.